JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120740

(±)-SKF38393 hydrochloride, D1-like dopamine receptor agonist

Be the first to review this product! Submit a review

|

(1 Publication)

MW 291.77 Da, Purity >98%. D1-like dopamine receptor agonist. pKi values are 9 (D1), 6.8 (D2), 5.3 (D3), 6.0 (D4) and 9.3 (D5). Ki values are 151 and 2364 nM for D1-like and D2-like dopamine receptors, respectively. Centrally active upon systemic administration.
1 Images
Chemical Structure - (±)-SKF38393 hydrochloride, D1-like dopamine receptor agonist (AB120740)
  • Chemical Structure

Lab

Chemical Structure - (±)-SKF38393 hydrochloride, D1-like dopamine receptor agonist (AB120740)

2D chemical structure image of ab120740, SKF38393 hydrochloride, D1-like dopamine receptor agonist

Key facts

CAS number

62717-42-4

Purity

>98%

Form

Solid

form

Molecular weight

291.77 Da

Molecular formula

C<sub>1</sub><sub>6</sub>H<sub>1</sub><sub>8</sub>ClNO<sub>2</sub>

PubChem

147514

Nature

Synthetic

Solubility

Soluble in water to 25 mM

Soluble in DMSO to 100 mM

Biochemical name

1H-3-Benzazepine-7,8-diol, 2,3,4,5-tetrahydro-1-phenyl-, hydrochloride

Biological description

D1-like dopamine receptor agonist. pKi values are 9 (D1), 6.8 (D2), 5.3 (D3), 6.0 (D4) and 9.3 (D5). Ki values are 151 and 2364 nM for D1-like and D2-like dopamine receptors, respectively. Centrally active upon systemic administration.

Canonical smiles

C1CNCC(C2=CC(=C(C=C21)O)O)C3=CC=CC=C3.Cl

InChi

InChI=1S/C16H17NO2.ClH/c18-15-8-12-6-7-17-10-14(13(12)9-16(15)19)11-4-2-1-3-5-11;/h1-5,8-9,14,17-19H,6-7,10H2;1H

InChiKey

YEWHJCLOUYPAOH-UHFFFAOYSA-N

IUPAC Name

5-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol;hydrochloride

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Scientific reports 6:23527 PubMed26997328

2016

Inhibition of Glycogen Synthase Kinase-3β (GSK-3β) as potent therapeutic strategy to ameliorates L-dopa-induced dyskinesia in 6-OHDA parkinsonian rats.

Applications

Unspecified application

Species

Unspecified reactive species

Cheng-long Xie,Jing-Ya Lin,Mei-Hua Wang,Yu Zhang,Su-fang Zhang,Xi-Jin Wang,Zhen-Guo Liu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com